Does a Graf Type-I Hip Justify the Discontinuation of Pavlik Harness Treatment in Patients with Developmental Dislocation of the Hip?
Yiqiang LiFederico CanaveseYanhan LiuJianping WuJingchun LiZhe YuanQinghe ZhouYuanzhong LiuWeidong ChenHongwen XuPublished in: Children (Basel, Switzerland) (2022)
In patients with DDH treated by PH, Graf type-I on US is not an absolute timing to terminate PH treatment. In addition, patients ≥ 13 weeks had a high risk of RAD despite PH treatment as 51.1% of infants developed RAD during follow up. Follow-up radiographs should be requested in all patients achieving Graf type-I hips at completion of PH treatment.